Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
FDA Approves Etcamah Breast Cancer Pill: Who Is Eligible?
5+ day, 4+ hour ago (491+ words) The US Food and Drug Administration (FDA) approved camizestrant, a new pill from AstraZeneca, for certain adults with advanced breast cancer. The medication will be marketed as Etcamah and received accelerated approval, a regulatory pathway intended to facilitate access to…...
Breast Cancer Drug Wins Accelerated Approval Four Months After FDA Advisers Voted Six to Three Against It
5+ day, 6+ hour ago (634+ words) The FDA has approved a breast cancer drug that its own expert advisers recommended against roughly four months earlier, and the record of that disagreement is now part of how patients and oncologists will weigh the treatment. Advisory committee votes…...
What To Know About New MRNA Flu Vaccine
5+ day, 21+ hour ago (843+ words) This article originally appeared on the Bloomberg School of Public Health website. An mRNA flu vaccine is on its way. On Aug. 5, the U.S. Food and Drug Administration approved Moderna's mFLUSIVA, the first influenza vaccine to use mRNA technology, for adults…...
GSK advances dual-antigen mRNA flu vaccine to Phase III after positive Phase II
1+ week, 5+ day ago (398+ words) AllSci Positive Phase II data for GSK's mRNA seasonal influenza vaccine candidate FLUm3HA.b-3NA have cleared the bar for a Phase III efficacy trial, with the UK giant reporting higher immune responses against all tested influenza strains compared to both standard-dose and…...
GSK's mRNA Flu Vaccine Heads to Phase III
1+ week, 5+ day ago (370+ words) A new generation of influenza vaccines may be taking shape. GSK announced on Sept. 1, 2026, that it will advance its investigational mRNA seasonal flu vaccine candidate into a pivotal Phase III trial following positive Phase II results presented at the OPTIONS…...
GSK Advances mRNA Flu Shot to Phase 3 After Beating Standard Vaccines in Mid-Stage Trial — BigGo Finance
1+ week, 5+ day ago (562+ words) GSK is moving its experimental mRNA-based seasonal flu vaccine into a late-stage trial after mid-stage data showed it generated stronger immune responses than conventional shots, positioning the British drugmaker to challenge Moderna's recently approved mRNA flu product. GSK did not…...
GSK takes dual-target mRNA flu shot to Phase III
1+ week, 5+ day ago (11+ words) FirstWord Pharma...
GSK???s Pivotal Test for mRNA Flu Vaccine Aims to Show Two Targets Are Better Than One
1+ week, 5+ day ago (465+ words) GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of the virus. That could be an advantage over Moderna’s recently approved mRNA flu shot, which addresses just one of…...
GSK Advances mRNA Flu Vaccine to Phase III
1+ week, 5+ day ago (255+ words) GSK is advancing its mRNA seasonal influenza vaccine candidate FLUm3HA.b-3NA into a Phase III efficacy trial starting in September. GSK intends to move its mRNA seasonal influenza vaccine candidate to a Phase III efficacy trial starting in September. The move is…...
GSK to launch Phase 3 test of mRNA flu vaccine with newer formulation
1+ week, 6+ day ago (157+ words) Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these cookies by checking "Do Not Sell or Store My Personal…...